📣 VC round data is live. Check it out!
- Public Comps
- Ezaki Glico Co
Ezaki Glico Co Valuation Multiples
Discover revenue and EBITDA valuation multiples for Ezaki Glico Co and similar public comparables like Tate & Lyle, Universal Robina, Cisarua Mountain Dairy, Yankershop Food Co and more.
Ezaki Glico Co Overview
About Ezaki Glico Co
Ezaki Glico Co Ltd is a Japanese food company. The reportable segments of the company are Health and Food Business includes the production and sales of health-related products, retort-packed food and others; Dairy Food Business includes the production and sales of dairy products, western-style fresh confectioneries, ice cream and others; Nutritional Confectionery Business includes the production and sales of chocolate, cookies and others; Food Ingredients Business: includes the production and sales of wheat protein, starch, food colouring and others; Other Domestic Business includes directly managed stores business, Office Glico business and others and Overseas Business includes the production and sales of chocolate, cookies and others overseas.
Founded
1929
HQ

Employees
9.0K
Website
Sectors
Financials (LTM)
EV
$2B
Valuation Multiples
Start free trialEzaki Glico Co Financials
Ezaki Glico Co reported last 12-month revenue of $2B and EBITDA of $194M.
In the same LTM period, Ezaki Glico Co generated $961M in gross profit, $194M in EBITDA, and $44M in net income.
Ezaki Glico Co P&L
In the most recent fiscal year, Ezaki Glico Co reported revenue of $2B and EBITDA of $185M.
Ezaki Glico Co is profitable as of last fiscal year, with gross margin of 37%, EBITDA margin of 8%, and net margin of 1%.
Financial data powered by Morningstar, Inc.
Ezaki Glico Co Stock Performance
Ezaki Glico Co has current market cap of $2B, and enterprise value of $2B.
Ezaki Glico Co's stock price is $35.18.
Ezaki Glico Co has an EPS (earnings per share) of $0.52.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | 0.1% | — | — | — | $0.52 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialEzaki Glico Co Valuation Multiples
Ezaki Glico Co trades at 0.8x EV/Revenue multiple, and 9.7x EV/EBITDA.
Ezaki Glico Co Financial Valuation Multiples
As of May 10, 2026, Ezaki Glico Co has market cap of $2B and EV of $2B.
Ezaki Glico Co has a P/E ratio of 50.5x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Ezaki Glico Co Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Ezaki Glico Co Margins & Growth Rates
Ezaki Glico Co grew revenue by 3% and EBITDA by 14% in the last fiscal year.
In the most recent fiscal year, Ezaki Glico Co reported gross margin of 37%, EBITDA margin of 8%, and net margin of 1%.
Ezaki Glico Co Margins
Ezaki Glico Co Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Ezaki Glico Co Operational KPIs
Ezaki Glico Co's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Ezaki Glico Co's Rule of 40 is 14% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Ezaki Glico Co's Rule of X is 22% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Ezaki Glico Co Competitors
Ezaki Glico Co competitors include Tate & Lyle, Universal Robina, Cisarua Mountain Dairy, Yankershop Food Co, Monde Nissin, Mayora Indah, Premier Foods, Chagee, AVI and Savola Group.
Most Ezaki Glico Co public comparables operate across Food & Beverages.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.5x | 1.3x | 6.9x | 6.3x | |||
| 0.8x | — | 6.8x | — | |||
| 3.2x | 3.1x | 13.7x | 13.4x | |||
| 2.8x | 2.7x | 14.6x | 13.8x | |||
| 1.3x | — | 7.8x | — | |||
| 1.1x | 1.1x | 8.8x | 8.4x | |||
| 1.7x | 1.6x | 8.4x | 8.6x | |||
| 0.5x | 0.5x | 4.1x | 3.6x | |||
This data is available for Pro users. Sign up to see all Ezaki Glico Co competitors and their valuation data. Start Free Trial | ||||||
Ezaki Glico Co Investment Activity
Ezaki Glico Co has invested in 2 companies to date.
Latest investment by Ezaki Glico Co was on October 11th 2022. Ezaki Glico Co invested in Viome in their $67M Series C round (EV/Revenue multiple of ).
Latest Investments by Ezaki Glico Co
| Description | Viome is a Bellevue-headquartered precision health company analyzing microbiome, mitochondrial, and cellular data through at-home test kits. Established in 2016, it provides personalized nutrition and lifestyle recommendations based on RNA sequencing of gut, oral, and cellular samples. The platform tracks biological age and health metrics for users seeking optimized wellness plans. | Viome is a Bellevue-headquartered precision health company analyzing microbiome, mitochondrial, and cellular data through at-home test kits. Established in 2016, it provides personalized nutrition and lifestyle recommendations based on RNA sequencing of gut, oral, and cellular samples. The platform tracks biological age and health metrics for users seeking optimized wellness plans. | FiNC Technologies is a Tokyo-based health technology firm that develops the FiNC app for wellness management. The platform integrates AI-powered personalized coaching, activity tracking, meal logging, and social challenges to help users monitor weight, steps, sleep, and nutrition. Partnerships with insurers like Sony Life provide premium features, while machine learning algorithms deliver tailored health insights to millions of Japanese users. |
| HQ Country | |||
| HQ City | Seattle, WA | Seattle, WA | Nishikicho |
| Deal Date | 11 Oct 2022 | 10 Nov 2021 | 20 Sep 2018 |
| Round | Series C | Series C | Series D |
| Raised | $67M | $54M | $49M |
| Investors | Better Health Group; Bold Capital Partners; Ezaki Glico; Khosla Ventures; Ocgrow Ventures; WestRiver Group | Better Health Group; Bold Capital Partners; Ezaki Glico; Khosla Ventures; Ocgrow Ventures; WestRiver Group | Artra Group; Chubu Electric Power; Dai-ichi Life; Ezaki Glico; Hiroshima Venture Capital; J-WAVE; Kodansha; Mizuho Securities; NEC; Rohto Pharmaceutical; SBI Investment; Shiseido |
| Valuation | $339M | undisclosed | undisclosed |
| EV/Revenue | |||
| EV/EBITDA | |||
This data is available for Pro users. Sign up to see all Ezaki Glico Co investments and their VC round multiples. Start Free Trial | |||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Ezaki Glico Co
| When was Ezaki Glico Co founded? | Ezaki Glico Co was founded in 1929. |
| Where is Ezaki Glico Co headquartered? | Ezaki Glico Co is headquartered in Japan. |
| How many employees does Ezaki Glico Co have? | As of today, Ezaki Glico Co has over 9K employees. |
| Is Ezaki Glico Co publicly listed? | Yes, Ezaki Glico Co is a public company listed on Tokyo Stock Exchange. |
| What is the stock symbol of Ezaki Glico Co? | Ezaki Glico Co trades under 2206 ticker. |
| When did Ezaki Glico Co go public? | Ezaki Glico Co went public in 1961. |
| Who are competitors of Ezaki Glico Co? | Ezaki Glico Co main competitors include Tate & Lyle, Universal Robina, Cisarua Mountain Dairy, Yankershop Food Co, Monde Nissin, Mayora Indah, Premier Foods, Chagee, AVI, Savola Group. |
| What is the current market cap of Ezaki Glico Co? | Ezaki Glico Co's current market cap is $2B. |
| What is the current revenue of Ezaki Glico Co? | Ezaki Glico Co's last 12 months revenue is $2B. |
| What is the current revenue growth of Ezaki Glico Co? | Ezaki Glico Co revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of Ezaki Glico Co? | Current revenue multiple of Ezaki Glico Co is 0.8x. |
| Is Ezaki Glico Co profitable? | Yes, Ezaki Glico Co is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Ezaki Glico Co? | Ezaki Glico Co's last 12 months EBITDA is $194M. |
| What is Ezaki Glico Co's EBITDA margin? | Ezaki Glico Co's last 12 months EBITDA margin is 8%. |
| What is the current EV/EBITDA multiple of Ezaki Glico Co? | Current EBITDA multiple of Ezaki Glico Co is 9.7x. |
| What is the current FCF of Ezaki Glico Co? | Ezaki Glico Co's last 12 months FCF is $113M. |
| What is Ezaki Glico Co's FCF margin? | Ezaki Glico Co's last 12 months FCF margin is 5%. |
| What is the current EV/FCF multiple of Ezaki Glico Co? | Current FCF multiple of Ezaki Glico Co is 16.6x. |
| How many companies Ezaki Glico Co has acquired to date? | Ezaki Glico Co hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Ezaki Glico Co has invested to date? | As of May 2026, Ezaki Glico Co has invested in 2 companies. |
| What was the last Ezaki Glico Co investment? | On 11th October 2022 Ezaki Glico Co invested in Viome, participating in a $67M Series C round at $339M valuation, alongside Better Health Group, Bold Capital Partners, Ezaki Glico, Khosla Ventures, Ocgrow Ventures, and WestRiver Group. |
| In what companies Ezaki Glico Co invested in? | Ezaki Glico Co invested in Viome and FiNC Technologies. |
See public comps similar to Ezaki Glico Co
Lists including Ezaki Glico Co
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

